Skip to main content
. 2012 Mar 14;7(3):e33095. doi: 10.1371/journal.pone.0033095

Table 1. Clinical patients’ characteristics.

Parameters Overall populationn = 100 Septicn = 37 (37%) Non-Septicn = 63 (63%) p value
Age (years) 37±17 35±16 38±17 .34 *
Male,% (n) 73% (n = 73) 81% (n = 30) 68% (n = 43) .24
ISS 37±10 39±8 35±10 .06 *
Severe brain injury,% (n) 38% (n = 38) 57% (n = 21) 27% (n = 17) .006
Severe thoracic injury,% (n) 74% (n = 74) 62% (n = 23) 81% (n = 51) .07
SAPS II 36.4±15.4 42.5±15.8 32.8±14.1 .002 *
Need for vasoactive support in emergency room,% (n) 26% (n = 26) 38% (n = 14) 19% (n = 12) .07
Prophylactic antibiotics administrated in emergency room,% (n) 42% (n = 42) 38% (n = 14) 44% (n = 28) .66
SOFA score
D1 4 [2]; [7] 7 [4.25; 10] 3[2]; [5] <.0001
D2 4 [2]; [6] 6[3.5; 10] 2.5 [1]; [5] <.0001
D3 3 [2]; [6] 7 [3.5; 9] 2 [1]; [3] <.0001
D4 3 [1]; [5] 5.5 [2.5; 8] 2 [1]; [3] <.0001
D5 2 [1]; [4] 5 [1.5; 7.5] 1 [1]; [3] <.0001
D6 1 [1]; [4] 4 [1.5; 7] 1 [1]; [2] <.0001
Shock (need for vasoactive drug on D1–2),% (n) 35% (n = 35) 59% (n = 22) 21% (n = 13) .0002
Mechanical ventilation (MV),% (n) 66% (n = 66) 89% (n = 33) 52% (n = 33) .0004
Duration of MV, days 6 [3]; [12] 10 [6]; [19] 3 [2; 5.25] <.0001
Massive transfusion required,% (n) 32% (n = 32) 40% (n = 15) 27% (n = 17) .24
Volume of global transfusion, ml 900 [0; 3,050] 1,800 [150; 4,300] 0 [0; 2,700] .02
Length of stay in ICU, days 9.5 [6]; [15] 15 [10.75; 24.25] 7 [5; 10.75] <.0001
Non-survivors at day 28,% (n) 5% (n = 5) 8% (n = 3) 3% (n = 2) .06

Parametric variables are expressed as mean ± standard deviation, and non-parametric variables as median (interquartile range) or frequencies.

*Independent samples t-test.

Mann & Whitney test.

Chi-square test

Abbreviations: ISS, Injury Severity Score; SAPS, Simple Acute Physiology Score; SOFA, Sequential Organ Failure Assessment; HLA, Human Leukocyte Antigen; ICU, Intensive Care Unit; D, day; IL, Interleukin.